Ke Pu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ke Pu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hao-Ying Wang
Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China
2 shared publications - Su-Yang Bai
Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China
2 shared publications - Yongning Zhou
Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China
2 shared publications - Yuping Wang
Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China
2 shared publications - GuoDong Yang
Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China
1 shared publication - Haiyue Zhou
Department of Gastroenterology, the Affiliated Hospital of North Sichuan Medical College, Sichuan, China
1 shared publication
Latest Publications
- Open Access
- 23 April 2025
- Published by Springer Nature in Research Square
Sinle-Cell Transcriptomics and Machine Learning Algorithms Unveil Metastasis-Associated Cellular Subtypes and Prognostic Signatures in Colorectal Cancer
Background Colorectal cancer (CRC) is a prevalent digestive tract malignancy, with liver metastasis occurring in up to 50% of cases. Identifying reliable early metastasis markers is crucial for improving CRC prognosis. Methods In this study, we analyzed single-cell RNA sequencing data from CRC patients, including primary tumors, adjacent normal tissues, and liver metastases. Copy number variation (CNV) analysis using CopyKAT algorithm distinguished tumor from non-tumor cells. We identified key tumor subtypes influencing metastasis through differential gene expression and pathway analyses. Leveraging 103 machine learning algorithms, we developed a metastasis-associated risk model based on identified biomarkers. The model was validated across multiple external datasets.. Results We delineated five tumor cell subtypes, with EMP1 + cells emerging as a key subtype in CRC metastasis. The machine learning approach identified a five-gene signature (SPINK1, PLAC8, LAMB3, CEACAM5, CDA) for metastasis risk prediction. The risk model significantly stratified patients into high- and low-risk groups across six independent cohorts, with high-risk scores correlating with poorer survival. Gene set enrichment analysis revealed enrichment of epithelial-mesenchymal transition (EMT) pathways in the high-risk group. Mutation analysis showed higher overall mutation frequencies in the high-risk group, particularly in genes like APC, TP53, and KRAS. Conclusion Our single-cell transcriptomics and machine learning approach uncovered novel cellular subtypes and a gene signature associated with CRC metastasis, providing new insights for early diagnosis and potential therapeutic targets.
- 23 April 2025
- Published by Springer Nature in Research Square
Open AccessSinle-Cell Transcriptomics and Machine Learning Algorithms Unveil Metastasis-Associated Cellular Subtypes and Prognostic Signatures in Colorectal Cancer
Background Colorectal cancer (CRC) is a prevalent digestive tract malignancy, with liver metastasis occurring in up to 50% of cases. Identifying reliable early metastasis markers is crucial for improving CRC prognosis. Methods In this study, we analyzed single-cell RNA sequencing data from CRC patients, including primary tumors, adjacent normal tissues, and liver metastases. Copy number variation (CNV) analysis using CopyKAT algorithm distinguished tumor from non-tumor cells. We identified key tumor subtypes influencing metastasis through differential gene expression and pathway analyses. Leveraging 103 machine learning algorithms, we developed a metastasis-associated risk model based on identified biomarkers. The model was validated across multiple external datasets.. Results We delineated five tumor cell subtypes, with EMP1 + cells emerging as a key subtype in CRC metastasis. The machine learning approach identified a five-gene signature (SPINK1, PLAC8, LAMB3, CEACAM5, CDA) for metastasis risk prediction. The risk model significantly stratified patients into high- and low-risk groups across six independent cohorts, with high-risk scores correlating with poorer survival. Gene set enrichment analysis revealed enrichment of epithelial-mesenchymal transition (EMT) pathways in the high-risk group. Mutation analysis showed higher overall mutation frequencies in the high-risk group, particularly in genes like APC, TP53, and KRAS. Conclusion Our single-cell transcriptomics and machine learning approach uncovered novel cellular subtypes and a gene signature associated with CRC metastasis, providing new insights for early diagnosis and potential therapeutic targets.
- Open Access
- 4 February 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (5) , e28741
A reliable nomogram model for predicting esophageal stricture after endoscopic submucosal dissection
Currently, endoscopic submucosal dissection (ESD) has gradually become the diagnosis and treatment of choice for initial esophageal cancer. However, the formation of esophageal stricture after ESD is one of its important complications. In this paper, we intend to identify the risk factors of esophageal stricture to develop a nomogram model to predict the risk of esophageal stricture and validate this model. A total, 159 patients were included in this study, including 21 patients with esophageal stenosis. Multivariate analysis showed that age greater than 60 years, high neutrophil-to-lymphocyte ratio, the extent of esophageal mucosal defect greater than 1/2, and postoperative pathological type of early esophageal squamous cell carcinoma were independent risk factors for predicting esophageal stricture. We constructed a nomogram model to predict esophageal stenosis by these 4 independent predictors. The prediction performance of the model was verified by the area under the receiver operating characteristic curve, the area under the receiver operating characteristic curve of the model was 0.889, and the sensitivity and specificity were 80.00% and 91.28%, respectively, indicating that the prediction performance of the model was good; The calibration curve constructed by internal cross-validation suggested that the predicted results of the nomogram agreed well with the actual observed values. The nomogram model has a high accuracy for predicting esophageal stricture after esophageal ESD and is extremely important to reduce or avoid the occurrence of esophageal stricture. But it needs more external and prospective validation.
- 4 February 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (5) , e28741
Open AccessA reliable nomogram model for predicting esophageal stricture after endoscopic submucosal dissection
Currently, endoscopic submucosal dissection (ESD) has gradually become the diagnosis and treatment of choice for initial esophageal cancer. However, the formation of esophageal stricture after ESD is one of its important complications. In this paper, we intend to identify the risk factors of esophageal stricture to develop a nomogram model to predict the risk of esophageal stricture and validate this model. A total, 159 patients were included in this study, including 21 patients with esophageal stenosis. Multivariate analysis showed that age greater than 60 years, high neutrophil-to-lymphocyte ratio, the extent of esophageal mucosal defect greater than 1/2, and postoperative pathological type of early esophageal squamous cell carcinoma were independent risk factors for predicting esophageal stricture. We constructed a nomogram model to predict esophageal stenosis by these 4 independent predictors. The prediction performance of the model was verified by the area under the receiver operating characteristic curve, the area under the receiver operating characteristic curve of the model was 0.889, and the sensitivity and specificity were 80.00% and 91.28%, respectively, indicating that the prediction performance of the model was good; The calibration curve constructed by internal cross-validation suggested that the predicted results of the nomogram agreed well with the actual observed values. The nomogram model has a high accuracy for predicting esophageal stricture after esophageal ESD and is extremely important to reduce or avoid the occurrence of esophageal stricture. But it needs more external and prospective validation.
- 19 January 2021
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 20 (9) , 667-674
The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer
Multidrug resistance (MDR) is one of the most significant reasons for the chemotherapeutics failure in gastric cancer. Although accumulating investigations and researches have been made to elucidate the mechanisms of multidrug resistance, the detail is far from completely understood. The importance of microRNAs in cancer chemotherapeutic resistance has been demonstrated recently, which provides a new strategy to overcome multidrug resistance. The different mechanisms are related to the phenomena of MDR itself and the roles of miRNAs in these multi-mechanisms by which MDR is acquired. In turn, the aim of this review was to summarize recent publications of microRNAs in regulating MDR in gastric cancer, thereby potentially developing as targeted therapies. Further unraveling the roles of microRNAs in MDR mechanisms including the ATP-binding cassette (ABC) transporter family, autophagy induction, cancer stem cell regulation, hypoxia induction, DNA damage and repair, epigenetic regulation, and exosomes in gastric cancer will be helpful for us to win the battle against it.
- 19 January 2021
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 20 (9) , 667-674
The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer
Multidrug resistance (MDR) is one of the most significant reasons for the chemotherapeutics failure in gastric cancer. Although accumulating investigations and researches have been made to elucidate the mechanisms of multidrug resistance, the detail is far from completely understood. The importance of microRNAs in cancer chemotherapeutic resistance has been demonstrated recently, which provides a new strategy to overcome multidrug resistance. The different mechanisms are related to the phenomena of MDR itself and the roles of miRNAs in these multi-mechanisms by which MDR is acquired. In turn, the aim of this review was to summarize recent publications of microRNAs in regulating MDR in gastric cancer, thereby potentially developing as targeted therapies. Further unraveling the roles of microRNAs in MDR mechanisms including the ATP-binding cassette (ABC) transporter family, autophagy induction, cancer stem cell regulation, hypoxia induction, DNA damage and repair, epigenetic regulation, and exosomes in gastric cancer will be helpful for us to win the battle against it.
- Open Access
- 1 September 2020
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 9 (9) , 5218-5232
COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
Background: The type IV collagen alpha chain (COL4A) family is a major component of the basement membrane (BM) that has recently been found to be involved in tumor angiogenesis and progression. However, the expression levels and the exact roles of distinct COL4A family members in gastric cancer (GC) have not been completely understood. Methods: Here, the expression levels of COL4As in GC and normal gastric tissues were calculated by using TCGA datasets and the predicted prognostic values by the GEPIA tool. Furthermore, the cBioPortal and Metascape tools were integrated to analyze the genetic alterations, correlations and potential functions of COL4As, and their frequently altered neighboring genes in GC. Results: Notably, the expression levels of COL4A1/2/4 in GC were higher to those in normal gastric tissues, while the expression levels of COL4A3/5/6 were lower in GC than normal. Survival analysis revealed that lower expression levels of COL4A1/5 led to higher overall survival (OS) rate. Multivariate analysis using the Cox proportional-hazards model indicated that age, gender, pathological grade, metastasis and COL4A5 expression, are independent prognostic factors for OS. However, TNM stage, lymph node metastasis, Lauren’s classification, COL4A1-4 and COL4A6 were associated with poor OS but not independent prognostic factors. Function-enriched analysis of COL4As and their frequently altered neighboring genes was involved in tumor proliferation and metastasis in GC. Conclusions: These results implied that COL4A1/2 were potential therapeutic targets for GC. COL4A3/4/6 might have an impact on gastric carcinogenesis and subsequent progression, whereas COL4A5 was an independent prognostic marker for GC.
- 1 September 2020
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 9 (9) , 5218-5232
Open AccessCOL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
Background: The type IV collagen alpha chain (COL4A) family is a major component of the basement membrane (BM) that has recently been found to be involved in tumor angiogenesis and progression. However, the expression levels and the exact roles of distinct COL4A family members in gastric cancer (GC) have not been completely understood. Methods: Here, the expression levels of COL4As in GC and normal gastric tissues were calculated by using TCGA datasets and the predicted prognostic values by the GEPIA tool. Furthermore, the cBioPortal and Metascape tools were integrated to analyze the genetic alterations, correlations and potential functions of COL4As, and their frequently altered neighboring genes in GC. Results: Notably, the expression levels of COL4A1/2/4 in GC were higher to those in normal gastric tissues, while the expression levels of COL4A3/5/6 were lower in GC than normal. Survival analysis revealed that lower expression levels of COL4A1/5 led to higher overall survival (OS) rate. Multivariate analysis using the Cox proportional-hazards model indicated that age, gender, pathological grade, metastasis and COL4A5 expression, are independent prognostic factors for OS. However, TNM stage, lymph node metastasis, Lauren’s classification, COL4A1-4 and COL4A6 were associated with poor OS but not independent prognostic factors. Function-enriched analysis of COL4As and their frequently altered neighboring genes was involved in tumor proliferation and metastasis in GC. Conclusions: These results implied that COL4A1/2 were potential therapeutic targets for GC. COL4A3/4/6 might have an impact on gastric carcinogenesis and subsequent progression, whereas COL4A5 was an independent prognostic marker for GC.